ENSEM Therapeutics is a biotechnology company focusing on high value and difficult-to-drug oncology targets
ENSEM Therapeutics has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in October 2023.
ENSEM Therapeutics's investors include Legend Star, Pavilion Capital, MegaRobo, GGV Capital, CBC Group.
ENSEM Therapeutics is headquartered in Medford, United States.
ENSEM Therapeutics is a biotechnology company focusing on high value and difficult-to-drug oncology targets
ENSEM Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ENSEM Therapeutics — Funding & Investors." VCBacked, October 23, 2023, https://www.vcbacked.co/company/ensem-therapeutics. Accessed October 30, 2026.
VCBacked. (2023). ENSEM Therapeutics — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/ensem-therapeutics
{{cite web |title=ENSEM Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ensem-therapeutics |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated